![Image](https://i0.wp.com/euis.eu/wp-content/uploads/2018/07/06_07_18_small.jpg?w=150&ssl=1)
Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer – but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.
Powered by WPeMatico
Related
Comments
comments